Physician Practice

Part B Payments for 340B Purchased Drugs

Physician Practice Insider, December 15, 2015

On November 24, the OIG posted a report stating that Medicare Part B and its beneficiaries paid $3.5 billion for 340B-purchased drugs in 2013. In the aggregate, Part B payment amounts were 58% more than the statutorily based 340B ceiling prices that year, which allowed covered entities to retain approximately $1.3 billion. The OIG states that this report presents an independent analysis to inform the ongoing discussion and to support decision makers’ efforts in striking a balance among the needs of these vital programs.

View the report.

This article was originally published on the Medicare Compliance Watch website.

Most Popular